Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
This study has been completed.
Study NCT00211939 Information provided by Nabi Biopharmaceuticals
First Received: September 13, 2005 Last Updated: December 26, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Calcinosis
Arteriosclerosis
Hyperparathyroidism, Secondary
Additional conditions recognized in this trial
Hyperparathyroidism
Neoplasm Metastasis
More general conditions related to this trial
Arterial Occlusive Diseases
Calcium Metabolism Disorders
Cardiovascular Diseases
Endocrine System Diseases
Metabolic Diseases
Neoplasms
Neoplastic Processes
Parathyroid Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
calcium acetate
sevelamer
atorvastatin
Additional drug interventions recognized in this trial
Calcium, Dietary
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Bone Density Conservation Agents
Chelating Agents
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Nabi Biopharmaceuticals
Back to top of Main Content
